Progressive Care, Inc. RXMD OTC

Other OTC • Healthcare • Medical - Pharmaceuticals • US • USD

SharesGrow Score

37/100

1/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Progressive Care, Inc. (RXMD) .

Criteria proven by this page:

VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 35/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score

37/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

0/100

→ Income

✓

HEALTH

100/100

Debt-to-Equity & liquidity

→ Health

✗

MOAT

36/100

→ Income

GROWTH

40/100

→ Income

✗

INCOME

10/100

→ Income

Valuation Snapshot — RXMD

Valuation Multiples

P/E (TTM)0.0

Forward P/EN/A

PEG RatioN/A

Forward PEGN/A

P/B Ratio0.00

P/S Ratio0.26

EV/EBITDA0.0

Per Share Data

EPS (TTM)$-2.36

Book Value / Share$0.00

Revenue / Share$8.03

FCF / Share$0.00

Yields & Fair Value

Earnings YieldN/A

Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year	EPS (Diluted)	Revenue	Net Income	Net Margin
2014	$-6.44	$11.27M	$-1.01M	-9%
2015	$-1.57	$13.64M	$-1.22M	-8.9%
2016	$0.12	$18.32M	$209.32K	1.1%
2017	$0.03	$20.11M	$49.25K	0.2%
2018	$-0.78	$20.94M	$-1.63M	-7.8%
2019	$-1.16	$32.63M	$-2.51M	-7.7%
2020	$-0.63	$38.94M	$-1.45M	-3.7%
2021	$-0.38	$38.85M	$-1.18M	-3%
2022	$-2.03	$40.6M	$-5.9M	-14.5%
2023	$-2.36	$49.73M	$-14.65M	-29.5%